Tempest Therapeutics issues unregistered warrant for up to 2,344,828 shares in inducement deal

Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc.

TPST

0.00

  • Tempest Therapeutics priced an inducement deal tied to existing warrants, issuing a new unregistered warrant in a private placement-style transaction.
  • One holder agreed to cash-exercise existing warrants for 1,172,414 shares at USD 1.73 per share, generating about USD 2 million gross proceeds.
  • In exchange, the investor received a new unregistered warrant for 2,344,828 shares at USD 1.73, exercisable after required Nasdaq stockholder approval.
  • H.C. Wainwright served as placement agent, receiving warrants for 82,069 shares with a USD 2.16 exercise price.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempest Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-251994), on June 02, 2026, and is solely responsible for the information contained therein.